Nexalin Technology R&D Spending Growth & History (NXL)

Nexalin Technology's r&d spending was $1.1M for fiscal 2025.

View full Nexalin Technology company overview

Nexalin Technology annual r&d spending history

Nexalin Technology annual r&d spending

Fiscal yearPeriod endedR&D spendingChangeGrowth
20252025-12-31$1.1M−$107,362−9.02%
20242024-12-31$1.2M−$730,927−38.03%
20232023-12-31$1.9M$1.4M+276.09%
20222022-12-31$511,000$372,000+267.63%
20212021-12-31$139,000

Nexalin Technology r&d spending trends

Between the periods ended 2021-12-31 and 2025-12-31, Nexalin Technology's r&d spending increased from $139,000 to $1.1M, a change of $944,522. The latest reported quarter, Q2 2026, shows $564,480.

About the metric

What research and development spending means

Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.

Calculation and source

SEC-reported R&D expense

TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Nexalin Technology source filings ↗

Community posts

It’s quiet here.

No posts about NXL yet. Start the conversation.

Write the first post